End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.022 AUD | -4.35% | +4.76% | +10.00% |
04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.00% | 17.44M | |
+42.69% | 749B | |
+38.46% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.72% | 248B | |
-2.54% | 214B | |
+11.18% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Pharmaxis Shrinks Fiscal H1 Loss